"Designing Growth Strategies is in our DNA"

Germany Hepatitis C Testing Market Size, Share & Analysis, By Test Types (HCV Serologic Tests (HCV Ab), HCV RNA Tests, and HCV Genotype Tests), By Technology Type (ELISA, and PCR), By End User (Hospitals, Diagnostics Labs, and Others) and Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI104866

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of hepatitis C in Germany
    2. Regulatory and Reimbursement Scenario
    3. Key Industry Developments
    4. Number of Hepatitis C Tests in Germany
    5. Technological Advancements in Testing
    6. Impact of COVID-19 Outbreak on the Germany Hepatitis C Testing Market
  5. Germany Hepatitis C Testing Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Test Type
      1. HCV Serologic Tests (HCV Ab)
      2. HCV RNA Tests
      3. HCV Genotype Tests
    3. Market Analysis, Insights and Forecast – By Technology Type
      1. ELISA
      2. PCR
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Diagnostics Labs
      3. Others
  6. Competitive Analysis
    1. Key Industry Developments
    2. Germany Market Share Analysis (2020)
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Siemens Healthcare GmbH
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. DiaSorin S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of hepatitis C in Germany
    2. Regulatory and Reimbursement Scenario
    3. Key Industry Developments
    4. Number of Hepatitis C Tests in Germany
    5. Technological Advancements in Testing
    6. Impact of COVID-19 Outbreak on the Germany Hepatitis C Testing Market
  5. Germany Hepatitis C Testing Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Test Type
      1. HCV Serologic Tests (HCV Ab)
      2. HCV RNA Tests
      3. HCV Genotype Tests
    3. Market Analysis, Insights and Forecast – By Technology Type
      1. ELISA
      2. PCR
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Diagnostics Labs
      3. Others
  6. Competitive Analysis
    1. Key Industry Developments
    2. Germany Market Share Analysis (2020)
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Siemens Healthcare GmbH
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. DiaSorin S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Table 01: Germany Hepatitis C Testing Market Revenue (USD million) Forecast, By Test Type, 2016–2027

Table 02: Germany Hepatitis C Testing Market Revenue (USD million) Forecast, by Technology Type, 2016–2027

Table 03: Germany Hepatitis C Testing Market Revenue (USD million) Forecast, by End-user, 2016–2027

  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (IN PROCESS)
  • 2024
    (IN PROCESS)
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann